Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-08-18

FDA Approved: GABAPENTIN — Original Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved BluePoint Laboratories' original application for gabapentin (generic). The approval covers its use as a generic option for partial-onset seizur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

ORIG AP for GABAPENTIN (GABAPENTIN)